Intrust Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Buy |
3,803
+197
| +5% | +$87.7K | 0.15% | 108 |
|
|
2025
Q1 | $1.75M | Buy |
3,606
+231
| +7% | +$112K | 0.17% | 105 |
|
|
2024
Q4 | $1.36M | Buy |
3,375
+4
| +0.1% | +$1.61K | 0.14% | 117 |
|
|
2024
Q3 | $1.57M | Buy |
3,371
+14
| +0.4% | +$6.51K | 0.16% | 114 |
|
|
2024
Q2 | $1.57M | Sell |
3,357
-55
| -2% | -$25.8K | 0.17% | 106 |
|
|
2024
Q1 | $1.43M | Buy |
3,412
+62
| +2% | +$25.9K | 0.15% | 119 |
|
|
2023
Q4 | $1.36M | Buy |
3,350
+309
| +10% | +$126K | 0.16% | 118 |
|
|
2023
Q3 | $1.06M | Buy |
3,041
+29
| +1% | +$10.1K | 0.13% | 133 |
|
|
2023
Q2 | $1.06M | Buy |
3,012
+115
| +4% | +$40.5K | 0.13% | 141 |
|
|
2023
Q1 | $913K | Buy |
2,897
+321
| +12% | +$101K | 0.12% | 152 |
|
|
2022
Q4 | $744K | Buy |
2,576
+205
| +9% | +$59.2K | 0.1% | 178 |
|
|
2022
Q3 | $686K | Buy |
2,371
+202
| +9% | +$58.4K | 0.11% | 171 |
|
|
2022
Q2 | $611K | Buy |
2,169
+450
| +26% | +$127K | 0.09% | 199 |
|
|
2022
Q1 | $448K | Buy |
1,719
+798
| +87% | +$208K | 0.06% | 261 |
|
|
2021
Q4 | $202K | Buy |
+921
| New | +$202K | 0.02% | 389 |
|
|
2021
Q3 | – | Sell |
-1,324
| Closed | -$267K | – | 391 |
|
|
2021
Q2 | $267K | Buy |
1,324
+120
| +10% | +$24.2K | 0.04% | 319 |
|
|
2021
Q1 | $258K | Sell |
1,204
-69
| -5% | -$14.8K | 0.04% | 323 |
|
|
2020
Q4 | $301K | Buy |
1,273
+488
| +62% | +$115K | 0.05% | 287 |
|
|
2020
Q3 | $214K | Buy |
+785
| New | +$214K | 0.04% | 311 |
|